1 – 10 of 125
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
(
- Contribution to journal › Article
- 2017
-
Mark
High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance.
(
- Contribution to journal › Article
-
Mark
Early diagnostic value of Bcl-3 localization in colorectal cancer.
(
- Contribution to journal › Article
-
Mark
Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.
(
- Contribution to journal › Article
- 2014
-
Mark
Co-ordination of cell cycle, migration and stem cell-like activity in breast cancer.
(
- Contribution to journal › Article
-
Mark
Breastfeeding in relation to risk of different breast cancer characteristics.
(
- Contribution to journal › Article
-
Mark
Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response.
(
- Contribution to journal › Article
-
Mark
Epithelial and Stromal MicroRNA Signatures of Columnar Cell Hyperplasia Linking Let-7c to Precancerous and Cancerous Breast Cancer Cell Proliferation.
(
- Contribution to journal › Article
- 2013
-
Mark
Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity
(
- Contribution to journal › Article